These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 769237

  • 21. [Treatment with piribedil in peripheral arterial diseases].
    Gatta L, Corti G, Bernasconi S.
    Minerva Med; 1976 May 19; 67(25):1668-70. PubMed ID: 778669
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Piribedil in arterial diseases].
    Cristol R, Arnaud F.
    Nouv Presse Med; 1976 May 19; 3(41-43):2573-4. PubMed ID: 4619431
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Amphetamine and piribedil in affective illness.
    Post RM, Jimerson DC, Silberman EK.
    Psychopharmacol Bull; 1980 Jan 19; 16(1):57-9. PubMed ID: 6987695
    [No Abstract] [Full Text] [Related]

  • 27. Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
    Rondot P, Bathien N, Dumas JL.
    Adv Neurol; 1975 Jan 19; 9():373-81. PubMed ID: 1096574
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical evaluation of cinnarizine in patients with cerebral circulatory deficiency.
    Toledo JB, Pisa H, Marchese M.
    Arzneimittelforschung; 1972 Feb 19; 22(2):448-51. PubMed ID: 4554633
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Piribedil--an oral dopamine agonist for treatment of Parkinson's disease.
    Sweet RD, Wasterlain C, McDowell FH.
    Trans Am Neurol Assoc; 1974 Feb 19; 99():258-60. PubMed ID: 4463553
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Value of piribedil in the treatment of degenerative retinal vasculopathies].
    Perdriel G, Chevaleraud JP, Decroix G.
    Bull Soc Ophtalmol Fr; 1974 Apr 19; 74(4):445-8. PubMed ID: 4219755
    [No Abstract] [Full Text] [Related]

  • 38. Piribedil therapy in Parkinson's disease. Use of the drug in the retard form.
    Mentenopoulos G, Katsarou Z, Bostantjopoulou S, Logothetis J.
    Clin Neuropharmacol; 1989 Feb 19; 12(1):23-8. PubMed ID: 2713865
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.